GGrantIndex
← Leaderboards

La Jolla Institute For Immunology

La Jolla, CA

Compare ↔
$670,920,942
Total funding
365
Grants

Funding over time

peak $76.1M · FY2006–25
$100M$75M$50M$25M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$670,920,942 · 365

By mechanism

R01$241,083,133 · 108
U19$120,554,258 · 68
N01$112,435,501 · 15
U01$57,113,066 · 14
P01$40,103,871 · 49
R35$18,812,683 · 4

Investigators at La Jolla Institute For Immunology

Investigator-initiatedAll funding

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

1Sam Anthony Myers$3,314,2783 gr2Benjamin Joachim Schmiedel$1,980,1363 gr3Parham Ramezani-Rad$1,767,1841 gr4Simon Eschweiler$1,061,7591 gr5Estefania Quesada Masachs$1,009,5001 gr6Mehdi Benkahla$503,2501 gr7Haoyang Li$496,3881 gr

Emerging Leaders

6–10 yrs in

1Ferhat Ay$6,126,3064 gr2Zhichao Fan$2,103,1751 gr3Vipul Shukla$1,332,4602 gr4Jennifer Marie Dan$511,7311 gr

All-Time

Most funded here, all years

1Michael Croft$21,883,37315 gr2Hilde Cheroutre$18,528,5257 gr3Sujan Shresta$14,084,96511 gr4Patrick Hogan$11,069,8536 gr5Christopher A Benedict$10,015,8358 gr6Alessandro Sette$9,498,0809 gr7Bjoern Peters$7,817,0605 gr8Pandurangan Vijayanand$6,950,5314 gr

Largest grants

New players in immune function: identification through RNAi and micro-RNA screens$12,579,073
RC4 · FY2010 · AI
Consortium for Immunotherapeutics against Emerging Viral Threats$7,168,390
U19 · FY2019 · AI
Consortium for Immunotherapeutics against Emerging Viral Threats$7,143,424
U19 · FY2020 · AI
Consortium for Immunotherapeutics against Emerging Viral Threats$7,065,330
U19 · FY2021 · AI
Consortium for Immunotherapeutics against Emerging Viral Threats$7,020,842
U19 · FY2022 · AI
Consortium for Immunotherapeutics against Emerging Viral Threats$7,006,270
U19 · FY2023 · AI
The Identification of HLA class I and class II T cell epitopes from Dengue Virus$5,982,817
N01 · FY2009 · AI
Identification of HLA class II T cell epitopes from Mycobacterium tuberculosis$5,839,818
N01 · FY2009 · AI
Functional and dysfunctional human CD4 T cell and B cell responses to bacteria and viruses$5,161,678
U19 · FY2021 · AI
T follicular helper (Tfh) CD4+ T cell, germinal center, and antibody response dysfunction in human recurrent tonsillitis$5,006,994
U19 · FY2021 · AI
Global Identification of Dengue Virus Epitopes Following Exposure, Vaccination, and Acute Infection$4,745,745
N01 · FY2014 · AI
Human immune signatures of Dengue virus and Mycobacterium Tuberculosis exposure in infection, disease and vaccination$4,556,424
U19 · FY2018 · AI
Targets of antibody responses in vaccinia virus & protection mechanisms$3,644,644
N01 · FY2009 · AI
IMMUNE EPITOPE AND ANALYSIS PROGRAM: Infectious Diseases$3,439,962
N01 · FY2020 · AI
Human immune signatures of Dengue virus and Mycobacterium Tuberculosis exposure in infection, disease and vaccination$3,238,555
U19 · FY2017 · AI
IMMUNE EPITOPE AND ANALYSIS PROGRAM: Infectious Diseases$3,202,752
N01 · FY2021 · AI
HIPC Data Coordinating Center$3,037,897
U01 · FY2023 · AI
HIPC Data Coordinating Center$3,020,173
U01 · FY2025 · AI
HIPC Data Coordinating Center$3,018,229
U01 · FY2024 · AI
Human immune signatures of Dengue virus and Mycobacterium Tuberculosis exposure in infection, disease and vaccination$3,015,851
U19 · FY2016 · AI